Prosecution Insights
Last updated: October 25, 2026

Realco

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Realco currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, WILLIAMS, EMMALEE RAE, within 1 distinct art unit. The 1 pending action indicates a very limited amount of active patent prosecution for the company. This data shows a singular technical focus within the biotechnology and pharmaceutical fields, suggesting a highly targeted intellectual property strategy.

The busiest examiner, WILLIAMS, EMMALEE RAE, holds the 1 pending office action. Because the portfolio involves only 1 distinct examiner and 1 distinct art unit, the prosecution is focused and straightforward. This structure allows the applicant to focus entirely on the specific examination standards of WILLIAMS, EMMALEE RAE. Practitioners should tailor their responses to the specific preferences of this 1 distinct examiner to navigate the 1 pending office action within the Biotechnology & Pharmaceuticals sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WILLIAMS, EMMALEE RAE 1 0.0% +0.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18874063 METHOD FOR SAMPLING MICROORGANISMS ON INDUSTRIAL AGRI-FOOD SURFACES WILLIAMS, EMMALEE RAE —

Top Art Units

Art UnitApps
1653 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18874063 METHOD FOR SAMPLING MICROORGANISMS ON INDUSTRIAL AGRI-FOOD SURFACES WILLIAMS, EMMALEE RAE 1653 §103§112 Non-Final OA — Pending Dec 11, 2024

Managing Realco's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Realco have?

Realco has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Realco applications?

Emmalee Rae Williams has the most, with 1 of Realco's pending office actions.

What technology area are Realco's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month